Aktie A2DNTF ASTEC LIFESCIENCES LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Astec LifeSciences Limited

Aktien

A2DNTF

INE563J01010

ASTEC

Markt geschlossen - NSE India S.E.
Andere Börsenplätze
 13:40:28 05.07.2024 		% 5 Tage % 1. Jan.
1 458 INR +0,48 % Intraday Chart für Astec LifeSciences Limited +13,45 % +33,16 %
14.06. India Ratings behält AA- Rating für Astec Lifesciences' Anleihen bei; Ausblick stabil MT
03.05. Astec Lifesciences' CFO tritt zurück MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
India Ratings Keeps AA- Rating on Astec Lifesciences' Bonds; Outlook Stable
Astec Lifesciences' CFO Resigns
Astec LifeSciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Astec LifeSciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Astec Lifesciences Limited Announces Resignation of Mr. K. Suryanarayan as Chief Financial Officer, Effective May 3, 2024
Astec Lifesciences Limited Announces Resignation of Vijay K. Khot as an Independent Director
India's Godrej family agree to split conglomerate into two
Nadir Godrej, Tanya Dubash, Nisaba Godrej and Pirojsha Godrej made an offer to acquire a 26% stake in Astec LifeSciences Limited for INR 5.4 billion
Astec LifeSciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Astec LifeSciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Astec Lifesciences Raises INR490 Million from Bond Issue
Astec LifeSciences Limited Declares Final Dividend for the Financial Year Ended March 31, 2023
Astec LifeSciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
India Ratings Gives AA- Rating to Astec Lifesciences' Bonds; Outlook Stable
Astec Lifesciences Swings to Loss in Fiscal Q4 as Revenue Halves
Astec LifeSciences Appoints CFO
Astec LifeSciences Limited Announces Chief Financial Officer Changes
Astec LifeSciences Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023, Payable by August 1, 2023
Astec LifeSciences Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Astec LifeSciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2DNTF Aktie
  4. Nachrichten Astec LifeSciences Limited
  5. Andere Sprachen